These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27133662)

  • 1. Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis.
    Huijbers MG; Niks EH; Klooster R; de Visser M; Kuks JB; Veldink JH; Klarenbeek P; Van Damme P; de Baets MH; van der Maarel SM; van den Berg LH; Verschuuren JJ
    Neuromuscul Disord; 2016 Jun; 26(6):350-3. PubMed ID: 27133662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
    Furuta N; Ishizawa K; Shibata M; Tsukagoshi S; Nagamine S; Makioka K; Fujita Y; Ikeda M; Yoshimura S; Motomura M; Okamoto K; Ikeda Y
    Intern Med; 2015; 54(19):2497-501. PubMed ID: 26424311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MuSK myasthenia gravis with prolonged remission.
    Bouwyn JP; Magnier P; Bédat-Millet AL; Ahtoy P; Maltête D; Lefaucheur R
    Neuromuscul Disord; 2016 Jul; 26(7):453-4. PubMed ID: 27161384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
    Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
    Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
    J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.
    Reddel SW; Morsch M; Phillips WD
    Curr Opin Neurol; 2014 Oct; 27(5):558-65. PubMed ID: 25159928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
    Huijbers MG; Vink AF; Niks EH; Westhuis RH; van Zwet EW; de Meel RH; Rojas-García R; Díaz-Manera J; Kuks JB; Klooster R; Straasheijm K; Evoli A; Illa I; van der Maarel SM; Verschuuren JJ
    J Neuroimmunol; 2016 Feb; 291():82-8. PubMed ID: 26857500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?
    Del Mar Amador M; Vandenberghe N; Berhoune N; Camdessanché JP; Gronier S; Delmont E; Desnuelle C; Cintas P; Pittion S; Louis S; Demeret S; Lenglet T; Meininger V; Salachas F; Pradat PF; Bruneteau G
    Neuromuscul Disord; 2016 Jun; 26(6):342-6. PubMed ID: 27102004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
    Hain B; Hanisch F; Deschauer M
    Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
    Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
    J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up.
    Hosaka A; Takuma H; Ohta K; Tamaoka A
    Intern Med; 2012; 51(21):3077-9. PubMed ID: 23124154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.
    Mori S; Shigemoto K
    Autoimmun Rev; 2013 Jul; 12(9):912-7. PubMed ID: 23537506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.